Target intelligence / Profile preview

Elongator complex protein 1 pre-messenger RNA (ELP1 pre-mRNA)

Target
ELP1 pre-mRNA
Molecular classification
Nucleic acid, Pre-messenger RNA
01

Overview

Elongator complex protein 1 (ELP1) pre-messenger RNA is the primary transcript of the ELP1 gene, which encodes a vital scaffold protein for the Elongator complex. This complex is essential for RNA polymerase II-mediated transcriptional elongation and the chemical modification of wobble-position uridines in tRNAs. In patients with Familial Dysautonomia (FD), a specific point mutation (c.2204+6T>C) in intron 20 of the ELP1 pre-mRNA weakens the 5' splice site, leading to the frequent skipping of exon 20 during RNA processing. This results in a truncated mRNA and a severe deficiency of functional ELP1 protein, particularly in the nervous system, leading to the progressive loss of sensory and autonomic neurons. ELP1 pre-mRNA is a therapeutic target for splicing-modulating small molecules and antisense oligonucleotides (ASOs) that aim to correct this splicing defect. By promoting the inclusion of exon 20, these therapies restore the production of full-length ELP1 protein and potentially halt the progression of the disease.

Other names
IKBKAP pre-mRNAIKAP pre-mRNAElongator complex protein 1 precursor mRNAInhibitor of kappa light polypeptide gene enhancer in B-cells kinase complex-associated protein pre-mRNA
02

Mechanism of action

Splicing modulation to promote the inclusion of exon 20 in the mature mRNA transcript by stabilizing the U1 snRNP interaction at the 5' splice site.

03

Biological functions

RNA splicingProtein synthesis precursorTranscriptional elongationtRNA modification
04

Disease associations

Familial DysautonomiaRiley-Day syndromeHereditary Sensory and Autonomic Neuropathy Type III
05

Safety considerations

Off-target splicing of non-target genesPotential for systemic toxicity with small molecule modifiersTissue-specific splicing efficiency variationsPotential retinal toxicity (observed with some splicing modulators)
06

Interacting drugs

PTC717

4 more in the full profile.

07

Biomarkers

ELP1 exon 20 inclusion ratioELP1 protein levels in peripheral blood mononuclear cellsELP1 mRNA levels in skin fibroblasts

Beyond the preview

Go deeper on Elongator complex protein 1 pre-messenger RNA (ELP1 pre-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongator complex protein 1 pre-messenger RNA (ELP1 pre-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call